CLINICAL_TRIALS
trial_result
· 2023-02-08
Clinical Trial Update: Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis [Phase 2]
Summary
Phase 2 trial update assessing PF-04965842 monotherapy for moderate-to-severe atopic dermatitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-02-08